C. Nichols
Corporate Officer/Principal at ALKERMES PLC
Net worth: 2 M $ as of 2024-04-29
C. Nichols active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | - | - |
| Sales & Marketing | 2019-05-12 | - |
Career history of C. Nichols
Former positions of C. Nichols
| Companies | Position | Start | End |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Sales & Marketing | 2019-04-30 | 2020-04-30 |
| CELGENE | Sales & Marketing | 2017-12-31 | 2018-12-31 |
| BIOGEN INC. | Sales & Marketing | - | 2016-12-31 |
Training of C. Nichols
| Elon University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Ireland | 2 |
Operational
| Sales & Marketing | 4 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- C. Nichols
- Experience